Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
Smyth
M J
MJ
Research Centre for Cancer and Transplantation, University of Melbourne, Parkville, Victoria, Australia.
Pietersz
G A
GA
Farquhar
I
I
McKenzie
C
C
D000477:Alkylating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D000922:Immunotoxins / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D014407:Tumor Cells, Cultured
D000477:Alkylating Agents; D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D000922:Immunotoxins